March 23 (Reuters) - U.S. drugmaker Pfizer ( PFE ) and France's Valneva said on Monday their experimental Lyme disease vaccine showed more than 70% efficacy in a late-stage trial. Pfizer ( PFE ) said it had planned to seek U.S. regulatory approval for the vaccine called PF-07307405. There is currently no approved vaccine to prevent Lyme disease - spread...

Strengthens integrated advisory and technology-enabled solutions across complementary client base Completed the acquisition of all PA shares not previously owned for upfront consideration of approximately £1.2 billion (approximately $1.6 billion)1 Continue to expect transaction to be accretive to adjusted EPS2 in the first 12 months after close DALLAS, March 23, 2026 /PRNewswire/ -- Accelerating its growth strategy to redefine the asset...

LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle...

CHARLOTTE, N.C., March 23, 2026 /PRNewswire/ -- Sealed Air Corporation (Sealed Air ( SEE ) or the Company) today announced that it has received all regulatory approvals required to complete the Company's pending acquisition by funds affiliated with CD&R. The transaction is expected to close in April 2026, subject to the satisfaction of remaining customary closing conditions. The receipt of all...